期刊文献+

外泌体对肝细胞癌转移前生态位形成的影响 被引量:3

The influence of exosomes on the formation of pre-transfer niche of hepatocellular carcinoma
下载PDF
导出
摘要 肝细胞癌(HCC)有高发病率、高转移率、低生存率、治疗效果差等特点。转移前生态位是指远处器官发生必要的变化以创造适合肿瘤细胞定植的局部微环境。外泌体是具有多种生物学功能的细胞外囊泡,在转移前生态位的形成中起重要作用。本文总结了外泌体对转移前生态位的影响,包括在HCC转移前生态位中介导特异性器官转移、增加血管生成和血管通透性、促进基质细胞活化和细胞外基质重塑、诱导HCC免疫抑制和免疫监视、为HCC靶向治疗提供新依据等;指出了利用外泌体在HCC转移前生态位中的作用,筛选出能预测肿瘤转移、预后及治疗效果的生物标志物,对延缓HCC病情进展有潜在的临床意义。 The characteristics of hepatocellular carcinoma(HCC)is high incidence,high metastasis rate,low survival rate,and poor treatment effect.Pre-metastasis niche refers to the necessary changes in distant organs to create a local microenvironment suitable for tumor cell colonization.Exosomes are extracellular vesicles with multiple biological functions and play an important role in the formation of the pre-metastasis niche.This article summarizes the effects of exosomes on the pre-metastasis niche,including mediating specific organ metastasis in the pre-metastasis niche of HCC,increasing angiogenesis and vascular permeability,promoting stromal cell activation and extracellular matrix remodeling,and inducing HCC immunosuppression or immune surveillance,provide new basis for HCC targeted therapy,etc.It is pointed out that the use of exosomes in the pre-metastasis niche of HCC to screen out biomarkers that can predict tumor metastasis,prognosis and therapeutic effects has potential clinical significance for delaying the progression of HCC.
作者 朱金霞 刘光伟 杨培伟 Zhu Jinxia;Liu Guangwei;Yang Peiwei(Henan University of Traditional Chinese Medicine,Zhengzhou 450000,Henan,China;Department of Hepatology and Spleen-Stomach,The First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450000,Henan,China)
出处 《消化肿瘤杂志(电子版)》 2022年第4期378-383,389,共7页 Journal of Digestive Oncology(Electronic Version)
基金 国家自然科学基金资助项目(82003994) 河南省特色骨干学科中医学学科建设项目(STG-ZYXKY-2020017)。
关键词 外泌体 肝细胞癌 转移前生态位 肿瘤微环境 免疫调节 Exosomes Hepatocellular carcinoma Pre-transfer niche Tumor microenvironment Immune regulation
  • 相关文献

参考文献3

二级参考文献15

  • 1Mignot G, Roux S, Thery C, et al. Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med, 2006, 10: 376-388.
  • 2Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics, 2008, 8: 4083-4099.
  • 3Karpf AR. A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy. Epigenetics, 2006, 1: 116-120.
  • 4Setiadi AF, David MD, Seipp RP, et al. Epigenetic control of the immune escape mechanisms in malignant carcinomas. Mol Cell Biol, 2007, 27: 7886-7894.
  • 5Khan AN, Magner WJ, Tomasi TB. An epigenetie vaccine model active in the prevention and treatment of melanoma. J Transl Med, 2007, 5: 64.
  • 6Hao S, Moyana T, Xiang J. Review: cancer immunotherapy by exosome-based vaccines. Cancer Biother Radiopharm, 2007, 22: 692-703.
  • 7Wieckowski E, Whiteside TL. Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles. Immunol Res, 2006, 36: 247-254.
  • 8Setiadi AF, Omilusik K, David MD, et al. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. Cancer Res, 2008, 68: 9601-9607.
  • 9Iero M, Vatenti R, Huber V, ct al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ, 2008, 15: 80-88.
  • 10Yang Y, Xiu F, Cai Z, et al. Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells. J Cancer Res Clin Oncol, 2007, 133: 389-399.

共引文献126

同被引文献22

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部